(PharmaNewsWire.Com, May 04, 2017 ) According to Publisher, the Global Photomedicine Market is accounted for $313.23 million in 2015 and is expected to reach $426.89 million by 2022 growing at a CAGR of 4.5% during the forecast period. Growing geriatric population and rising awareness for beauty are some of the factors boosting the market growth. However, huge costs and product safety concerns are anticipated to hamper the market growth.
Some of the key players in Photomedicine market include Abbott Medical Optics Inc., Novartis, Philips, BIOLITEC, THOR Photomedicine Ltd, Quantel medical, Alma Lasers, Ltd., IRIDEX, QBMI PhotoMedicine, Switch Biotech, Syneron Medical Ltd., AngioDynamics, Wellman Center for Photomedicine, Spectranetics, Lumenis Ltd., Pfizer Inc., Colorado Skin & Vein and PhotoMedex.
Regions Covered: - North America o US o Canada o Mexico - Europe o Germany o France o Italy o UK o Spain o Rest of Europe - Asia Pacific o Japan o China o India o Australia o New Zealand o Rest of Asia Pacific - Rest of the World o Middle East o Brazil o Argentina o South Africa o Egypt
9 Company Profiling 9.1 Abbott Medical Optics Inc. 9.2 Novartis 9.3 Philips 9.4 BIOLITEC 9.5 THOR Photomedicine Ltd 9.6 Quantel medical 9.7 Alma Lasers, Ltd. 9.8 IRIDEX 9.9 QBMI PhotoMedicine 9.10 Switch Biotech 9.11 Syneron Medical Ltd. 9.12 AngioDynamics 9.13 Wellman Center for Photomedicine 9.14 Spectranetics 9.15 Lumenis Ltd., 9.16 Pfizer Inc. 9.17 Colorado Skin & Vein 9.18 PhotoMedex
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
